Abstract:BACKGROUND:An alarming increment in pathogenic resistance to existing anti-microbial agents is a serious problem and the treatment of these bacterial infections is becoming increasingly challenging. Therefore, there is an urgent need to develop novel antimicrobial agents.OBJECTIVE:As a part of our ongoing studies toward the development of novel antibacterial agents, the synthesis and antibacterial activity of a series of (Z)-5-((3-phenyl-1H-pyrazol-4-yl)methylene)-2-thioxothiazolidin-4-one derivatives will be discussed in this study.METHOD:(Z)-5-((3-phenyl-1H-pyrazol-4-yl)methylene)-2-thioxothiazolidin-4-one derivatives were designed, synthesized and evaluated for antibacterial activity. The structures were confirmed by IR, 1H NMR, 13C NMR and mass spectrometry. All of the synthesized compounds were evaluated in vitro using a 96-well microtiter plate and a serial dilution method to obtain their minimum inhibitory concentration (MIC) values against a variety of different strains, including multidrug-resistant clinical isolates.RESULTS:The antibacterial test in-vitro showed that most compounds in series 7 and 9 exhibited significant inhibitory activities against anaerobic bacteria (Streptococcus mutans) strains with a MIC value of 1 µg/mL. Compounds 7c and 9c showed the most potent activity against MRSA (3167 and 3506) with a minimum inhibitory concentration (MIC) value of 1 µg/mL, which is equivalent to moxifloxacin and greater than gatifloxacin, oxacillin and norfloxacin. Additionally, compound 9c showed potent antibacterial activity against Bacillus subtilis (aerobic bacteria) with a MIC value of 2 µg/mL.CONCLUSION:The work suggests that these type of rhodanine compounds had a better potent activity against MRSA compared with other perviously reported rhodanine derivatives, which might provide a valuable information for the development of new antibacterial agents against multidrug-resistant clinical isolates MRSA.

Novel 2-(benzo[d]thiazol-2-yl)-1-(3-methyl-5-substituted-phenyl-4,5- dihydropyrazol-1-yl)ethanone Derivatives: Synthesis and antibacterial activity

Novel 4-Bromo-2-(3-methyl-1-(substituted-phenylsulfonyl)-4,5-dihydro-1- H-pyrazol-5-yl)phenol Derivatives: Synthesis and Antibacterial Activity

Novel Dihydropyrazole Derivatives Linked with 4H-Chromene: Microwave-Promoted Synthesis and Antibacterial Activity

Synthesis, Structure, and Antibacterial Activity of Novel 5-Arylpyrazole Derivatives

Synthesis, Structure and Antibacterial Activity of Novel 1-(5-substituted-3-substituted-4,5-dihydropyrazol-1-yl)ethanone Oxime Ester Derivatives

Synthesis, structure and antibacterial activity of new 2-(1-(2-(substituted-phenyl)-5-methyloxazol-4-yl)-3-(2-substitued-phenyl)-4,5-dihydro-1H-pyrazol-5-yl)-7-substitued-1,2,3,4-tetrahydroisoquinoline derivatives.

Synthesis and Antibacterial Activities of N-[(1-aryl-3-phenyl-pyrazol-4-yl)methylene]-2-(halo-o-hydroxyphenyl)hydrazide Derivatives

Synthesis and Antibacterial Activity of Novel Triazolo[4,3-a]pyrazine Derivatives

Synthesis of 1-(2-(4-subsitituted) Phenyloxyethyl)-1,2,3-Triazole Derivatives and Their Antibacterial Activity

Synthesis, and Antibacterial Activity of Novel 4,5-Dihydro-1h-pyrazole Derivatives As DNA Gyrase Inhibitors.

Novel 23-Hydroxybetulinic Acid Derivatives: Semi-Synthesis and Antibacterial Activity

Novel Dihydropyrazole Derivatives Linked with Multi（hetero）aromatic Ring:Synthesis and Antibacterial Activity

Design, Synthesis and Antibacterial Evaluation of Some New 2-Phenyl-quinoline-4-carboxylic Acid Derivatives

Design, Synthesis and Antimicrobial Evaluation of Novel Benzoxazole Derivatives.

Synthesis And Antibacterial Activities Of 2-(1-Aryl-5-Methyl-1,2,3-Triazol-4-Yl)-1,3,4-Oxadiazole Derivatives

Synthesis and antimicrobial study of novel 4,5-disubstituted aryl-2,4-dihydro-3H-1,2,4-triazole-3-thoxone derivatives

Synthesis and Antimicrobial Evaluation of (Z)-5-((3-phenyl-1h-pyrazol-4- Yl)methylene)-2-thioxothiazolidin-4-one Derivatives

Facile Synthesis of Novel Benzotriazole Derivatives and Their Antibacterial Activities

Design and Synthesis of New 2-Aryl-4,5-dihydro-thiazole Analogues: in Vitro Antibacterial Activities and Preliminary Mechanism of Action

Synthesis and Biological Activities of Thio-Triazole Derivatives As Novel Potential Antibacterial and Antifungal Agents

Synthesis, structure and structure-activity relationship analysis of 3-tert-butoxycarbonyl-2-arylthiazolidine-4-carboxylic acid derivatives as potential antibacterial agents.